AML Samples Show High Concordance in Detection of Mutations by NGS at Local Institutions versus Central Laboratories

By sjmartinez • July 18, 2023

Borate U, Yang F, Press RD, Ruppert AS, Jones D, Caruthers S, Zhao W, Vergilio JA, Pavlick D, Juckett L, Norris BA, Bucy T, Burd A, Stein EM, Patel PA, Baer MR, Stock W, Schiller GJ, Blum W, Kovacsovics TJ, Litzow MR, Foran JM, Heerema NA, Rosenberg L, Marcus S, Yocum AO, Stefanos M, Druker BJ, Mims AS. AML Samples Show High Concordance in Detection of Mutations by NGS at Local Institutions versus Central Laboratories. Blood Adv. 2023 Jul 17:bloodadvances.2022009008. doi: 10.1182/bloodadvances.2022009008. Epub ahead of print. PMID: 37459200.

Tags: Hematology/Oncology, Publications

Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan[...]

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

Li YR, Fang Y, Niu S, Zhu Y, Chen Y, Lyu Z, Zhu E, Tian Y, Huang J, Rezek V, Kitchen S, Hsiai T, Zhou[...]

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Wilky BA, Schwartz GK, Gordon MS, El-Khoueiry AB, Bullock AJ, Henick B, Agulnik M, Singh A, Mahadevan D, Stebbing J, Delepine C, Chand D, Avagyan[...]